🔎 Trials Near Me

Početna › Ateroskleroza › Indiana

Kliničke studije za Ateroskleroza u državi Indiana

8 studija za Ateroskleroza traži sudionike na lokacijama u državi Indiana.

Gradovi u državi Indiana

Službeni tekst studije (engleski)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

  • Asha Clinical Research-Munster,Llc, Hammond
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • IU Health Bloomington, Bloomington
  • Indiana University Health Methodist Hospital, Indianapolis
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Cardiovascular Research of Northwest Indiana LLC, Munster
  • Velocity Clinical Research - Valparaiso, Valparaiso
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • NANI Research, Fort Wayne
  • Nephrology Physician's LLC, Mishawaka
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Evansville
  • Research Site, Evansville
  • Research Site, Indianapolis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • American Health Network Research Dept, Muncie
  • American Health Network Research Dept, Muncie
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06813911

Pharmacogenomic Informed Statin Prescribing

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
U tijeku regrutacija
Od 40 do 75 godina · Oba spola · Ažurirano 13. tra 2026. · NCT06568601

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.